Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | BCL9 | O00512 | 1/20 | 0.49 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14437515 | 0.93 | HTR2A (0.66) | HTR2ARAB9ASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL5827968 | 0.92 | HTR2A (0.80) | HTR2ARAB9AHTTALDH1A1BCL9 | |
| SCHEMBL27189134 | 0.91 | HTR2A (0.59) | HTR2ARAB9ANPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL22460617 | 0.90 | HTR2A (0.65) | HTR2ARAB9AHTTSMN1; SMN2ALDH1A1 | |
| SCHEMBL14621621 | 0.88 | HTR2A (0.74) | HTR2ARAB9AHTTALDH1A1BCL9 | |
| SCHEMBL16695904 | 0.88 | HTR2A (0.56) | HTR2ARAB9ANPC1HTTSMN1; SMN2 | |
| SCHEMBL4644851 | 0.88 | HTR2A (0.56) | HTR2ARAB9ANPC1HTTSMN1; SMN2 | |
| SCHEMBL6645015 | 0.88 | RAB9A (0.61) | HTR2ARAB9ANPC1HTTALDH1A1 | |
| SCHEMBL12491205 | 0.87 | HTR2A (0.69) | HTR2ARAB9AALDH1A1CYP2C19BCL9 | |
| SCHEMBL22033758 | 0.86 | HTR2A (0.55) | HTR2ARAB9ANPC1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3993130-B1 | LITHIUM-SULFUR BATTERY ELECTROLYTE AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2025-11-26 | — | — | EP | claimed |
| US-12183889-B2 | Lithium-sulfur battery electrolyte and lithium-sulfur battery comprising same | LG ENERGY SOLUTION, LTD. (KR) | 2024-12-31 | — | — | US | claimed |
| CN-114207902-B | Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same | 株式会社LG新能源 | 2024-10-01 | — | — | CN | claimed |
| US-20220263136-A1 | LITHIUM-SULFUR BATTERY ELECTROLYTE AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2022-08-18 | — | — | US | claimed |
| EP-3993130-A1 | LITHIUM-SULFUR BATTERY ELECTROLYTE AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2022-05-04 | — | — | EP | claimed |
| CN-114207902-A | Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same | 株式会社LG新能源 | 2022-03-18 | — | — | CN | claimed |
| EP-1242059-B1 | NOVEL PRODRUGS FOR ANTIMICROBIAL AMIDINES | UNIV NORTH CAROLINA (US) | 2007-03-21 | — | — | EP | claimed |
| US-6649652-B2 | Hypotensive agents; hyperglycemic agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2003-11-18 | — | — | US | claimed |
| US-20030092755-A1 | Novel prodrugs for antimicrobial amidines | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-05-15 | — | — | US | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-6395077-B1 | INKS WITH BENZOYLBENZOIC ACID AND COLORS | XEROX CORPORATION | 2002-05-28 | — | — | US | claimed |
| US-20020019437-A1 | Novel prodrugs for antimicrobial amidines | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-02-14 | — | — | US | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| US-4155902-A | ACYLATION, HYDROGENOLYSIS | ABBOTT LABORATORIES (US) | 1979-05-22 | — | — | US | claimed |
| US-20250381283-A1 | METHOD FOR TREATING SOLID TUMOR | BIO THERA SOLUTIONS LTD (CN) | 2025-12-18 | — | — | US | disclosed |
| EP-3993130-B1 | LITHIUM-SULFUR BATTERY ELECTROLYTE AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-20250355350-A1 | NEGATIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING PROCESS, METHOD FOR FORMING CURED COATING, INTERLAYER INSULATING FILM, SURFACE PROTECTING FILM, AND ELECTRONIC COMPONENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-11-20 | — | — | US | disclosed |
| US-4107424-A | ANTIBACTERIAL | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4104372-A | ANTIBACTERIAL | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1978-08-01 | — | — | US | disclosed |
| US-4001208-A | DERIVATIVE OF AN AMINOGLYCOSIDIC ANTIBIOTIC | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYO KAI (JA) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381283-A1 | METHOD FOR TREATING SOLID TUMOR | TPM4, TPM3, TPST2 | HTR2A 868/4885RAB9A 2836/4885NPC1 1799/4885 |
| US-20030092755-A1 | Novel prodrugs for antimicrobial amidines | NR1H3, APEH, NR1H2 | HTR2A 1877/4885RAB9A 1037/4885NPC1 503/4885 |
| US-20020019437-A1 | Novel prodrugs for antimicrobial amidines | NR1H3, APEH, NR1H2 | HTR2A 1877/4885RAB9A 1037/4885NPC1 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.